Bio-Reference Labs (BRLI) Reports In-Line Q4 EPS of 46c

December 6, 2012 8:31 AM EST
Bio-Reference Labs (NASDAQ: BRLI) reported Q4 EPS of $0.46, in-line with the analyst estimate of $0.46. Revenue for the quarter came in at $176.05 million versus the consensus estimate of $175.46 million.

For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment